Trial Profile
Clinical Trials Insight: 700018862
Status:
Planning
Phase of Trial:
Phase I/II
Latest Information Update: 22 Nov 2006
Price :
$35
*
At a glance
- Drugs Vitiligo-derived immunoglobulin G (Primary)
- Indications Malignant melanoma
- Focus Therapeutic Use
- 22 Nov 2006 New trial record.